Management of hand eczema. ICD-10-number: L20., L23., L24., L25., L30 [Management von handekzemen. ICD-10-ziffer: L20., L23., L24., L25., L30]

Autor(en): Diepgen, T.L.
Elsner, P.
Fartasch, M.
John, S.M. 
Köllner, A.
Schliemann, S.
Skudlik, C. 
Worm, M.
Stichwörter: alitretinoin, 5300-03-8; betamethasone, 378-44-9; clioquinol, 130-26-7, 8057-20-3; clobetasol propionate, 25122-46-7; desonide, 638-94-8; fluprednidene, 2193-87-5; fluprednidene acetate, 1255-35-2; mometasone furoate, 83919-23-7, 105102-22-5; alitretinoin; Allergic contact dermatitis; betamethasone; calcineurin inhibitor; chronic disease; clinical trial; clioquinol; clobetasol propionate; contact dermatitis; cost benefit analysis; cyclosporin A; desonide; Diagnositic; differential diagnosis; disease classification; disease severity; evidence based medicine; fluprednidene; fluprednidene acetate; glucocorticoid; Hand eczema; human; Irritant contact dermatitis; irritant dermatitis; keratolytic agent; mometasone furoate, atopic dermatitis; Patch test; pompholyx; practice guideline; Prevention; PUVA; quality of life; review; Therapy
Erscheinungsdatum: 2009
Herausgeber: Dustri-Verlag Dr. Karl Feistle
Journal: Dermatologie in Beruf und Umwelt
Volumen: 57
Ausgabe: 2
Startseite: 46
Seitenende: 64
Zusammenfassung: 
Hand eczema (HE) is one of the most frequent skin diseases. Eczema of the hands is not a homogenous disease entity, but instead occurs in various forms, and comprehensive differential diagnosis is often necessary. The disease can range in severity from very mild to chronic severe disease that can even prevent the patient from working for extended periods of time and may be refractory to treatment. Chronic hand eczema is very costly and involves significant impairment of the quality of life of the patient. Several therapy options are available, but the treatment of chronic hand eczema is often difficult and unsatisfactory. Therapy is complex and requires multimodal management. Large, high-quality, randomized controlled clinical studies on the effectiveness of even established therapy options are lacking. The following guideline provides a starting point for evidence-based approach to hand eczema, presenting the classification, diagnosis, prevention, therapy, and rehabilitation of this disease. © 2009 Dustri-Verlag Dr. Karl Feistle.
ISSN: 1438776X
DOI: 10.5414/dbp57046
Externe URL: https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349392665&doi=10.5414%2fdbp57046&partnerID=40&md5=8eab065ac5070d130a3b2c5414d9f5eb

Show full item record

Page view(s)

7
Last Week
0
Last month
0
checked on May 17, 2024

Google ScholarTM

Check

Altmetric